Petra Vrabcová

612 total citations
16 papers, 450 citations indexed

About

Petra Vrabcová is a scholar working on Immunology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Petra Vrabcová has authored 16 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 3 papers in Molecular Biology and 2 papers in Infectious Diseases. Recurrent topics in Petra Vrabcová's work include Immune Cell Function and Interaction (5 papers), Immunodeficiency and Autoimmune Disorders (4 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (4 papers). Petra Vrabcová is often cited by papers focused on Immune Cell Function and Interaction (5 papers), Immunodeficiency and Autoimmune Disorders (4 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (4 papers). Petra Vrabcová collaborates with scholars based in Czechia, France and Germany. Petra Vrabcová's co-authors include Anna Šedivá, Zuzana Paračková, Irena Zentsová, Adam Klocperk, Markéta Bloomfield, Jitka Smetanová, Tomáš Vymazal, Lenka Petruželková, Jana Kayserová and Štěpánka Průhová and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and Journal of the Science of Food and Agriculture.

In The Last Decade

Petra Vrabcová

16 papers receiving 440 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Petra Vrabcová Czechia 11 286 111 93 93 67 16 450
Carine El Sissy France 11 204 0.7× 202 1.8× 56 0.6× 53 0.6× 15 0.2× 25 451
A J Infante United States 12 312 1.1× 97 0.9× 176 1.9× 39 0.4× 30 0.4× 21 629
M. Betina Pampena Argentina 12 385 1.3× 333 3.0× 96 1.0× 38 0.4× 23 0.3× 23 562
Ester Blanco Spain 12 302 1.1× 398 3.6× 115 1.2× 59 0.6× 22 0.3× 31 611
Mirjana Urosevic‐Maiwald Switzerland 12 264 0.9× 190 1.7× 139 1.5× 19 0.2× 21 0.3× 24 583
Alexandra Joseph United States 7 162 0.6× 166 1.5× 51 0.5× 54 0.6× 16 0.2× 8 378
Christine‐Ivy Liacos Greece 12 111 0.4× 91 0.8× 178 1.9× 149 1.6× 11 0.2× 33 509
Rinat Eshel Israel 9 87 0.3× 147 1.3× 119 1.3× 79 0.8× 17 0.3× 19 325
Elizabeth Mroczek‐Musulman United States 13 42 0.1× 130 1.2× 199 2.1× 39 0.4× 82 1.2× 41 523
Clara Chong Hui Ong Singapore 11 204 0.7× 281 2.5× 162 1.7× 28 0.3× 12 0.2× 19 498

Countries citing papers authored by Petra Vrabcová

Since Specialization
Citations

This map shows the geographic impact of Petra Vrabcová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petra Vrabcová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petra Vrabcová more than expected).

Fields of papers citing papers by Petra Vrabcová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petra Vrabcová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petra Vrabcová. The network helps show where Petra Vrabcová may publish in the future.

Co-authorship network of co-authors of Petra Vrabcová

This figure shows the co-authorship network connecting the top 25 collaborators of Petra Vrabcová. A scholar is included among the top collaborators of Petra Vrabcová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petra Vrabcová. Petra Vrabcová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Paračková, Zuzana, Petra Vrabcová, Irena Zentsová, Anna Šedivá, & Markéta Bloomfield. (2023). Neutrophils in STAT1 Gain-Of-Function Have a Pro-inflammatory Signature Which Is Not Rescued by JAK Inhibition. Journal of Clinical Immunology. 43(7). 1640–1659. 5 indexed citations
2.
Vrabcová, Petra, Zuzana Paračková, Robert Haesler, et al.. (2023). Th1/interferon-γ bias in 22q11.2 deletion syndrome is driven by memory T cells and exacerbated by IL-7. Clinical Immunology. 256. 109793–109793. 3 indexed citations
3.
Paračková, Zuzana, Irena Zentsová, Petra Vrabcová, Anna Šedivá, & Markéta Bloomfield. (2022). Aberrant tolerogenic functions and proinflammatory skew of dendritic cells in STAT1 gain-of-function patients may contribute to autoimmunity and fungal susceptibility. Clinical Immunology. 246. 109174–109174. 6 indexed citations
4.
Klocperk, Adam, Petra Vrabcová, Irena Zentsová, et al.. (2021). Elevated Biomarkers of NETosis in the Serum of Pediatric Patients With Type 1 Diabetes and Their First-Degree Relatives. Frontiers in Immunology. 12. 699386–699386. 16 indexed citations
5.
Klocperk, Adam, Markéta Bloomfield, Zuzana Paračková, et al.. (2020). Complex Immunometabolic Profiling Reveals the Activation of Cellular Immunity and Biliary Lesions in Patients with Severe COVID-19. Journal of Clinical Medicine. 9(9). 3000–3000. 3 indexed citations
6.
Paračková, Zuzana, Irena Zentsová, Markéta Bloomfield, et al.. (2020). Disharmonic Inflammatory Signatures in COVID-19: Augmented Neutrophils’ but Impaired Monocytes’ and Dendritic Cells’ Responsiveness. Cells. 9(10). 2206–2206. 97 indexed citations
7.
Paračková, Zuzana, Tomáš Milota, Petra Vrabcová, et al.. (2020). Novel XIAP mutation causing enhanced spontaneous apoptosis and disturbed NOD2 signalling in a patient with atypical adult-onset Crohn’s disease. Cell Death and Disease. 11(6). 430–430. 10 indexed citations
8.
Paračková, Zuzana, Petra Vrabcová, Irena Zentsová, et al.. (2020). Enhanced STAT3 phosphorylation and PD-L1 expression in myeloid dendritic cells indicate impaired IL-27Ralpha signaling in type 1 diabetes. Scientific Reports. 10(1). 493–493. 16 indexed citations
9.
Paračková, Zuzana, Irena Zentsová, Petra Vrabcová, et al.. (2020). Neutrophil Extracellular Trap Induced Dendritic Cell Activation Leads to Th1 Polarization in Type 1 Diabetes. Frontiers in Immunology. 11. 661–661. 50 indexed citations
10.
Paračková, Zuzana, Markéta Bloomfield, Petra Vrabcová, et al.. (2019). Mutual alteration of NOD2-associated Blau syndrome and IFNγR1 deficiency. Journal of Clinical Immunology. 40(1). 165–178. 10 indexed citations
11.
Zentsová, Irena, Zuzana Paračková, Jana Kayserová, et al.. (2019). Monocytes contribute to DNA sensing through the TBK1 signaling pathway in type 1 diabetes patients. Journal of Autoimmunity. 105. 102294–102294. 16 indexed citations
12.
Bloomfield, Markéta, Veronika Kanderová, Zuzana Paračková, et al.. (2018). Utility of Ruxolitinib in a Child with Chronic Mucocutaneous Candidiasis Caused by a Novel STAT1 Gain-of-Function Mutation. Journal of Clinical Immunology. 38(5). 589–601. 55 indexed citations
13.
Vávrová, Kateřina, Petra Vrabcová, Dominik Filipp, Jiřina Bartůňková, & Rudolf Horváth. (2016). Generation of T cell effectors using tumor cell-loaded dendritic cells for adoptive T cell therapy. Medical Oncology. 33(12). 136–136. 6 indexed citations
14.
Horváth, Rudolf, Étienne Becht, Daniela Rožková, et al.. (2015). Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer. Oncotarget. 6(20). 18192–18205. 109 indexed citations
15.
Novotná, Eva, et al.. (2010). Highly active antimycobacterial derivatives of benzoxazine. Bioorganic & Medicinal Chemistry. 18(23). 8178–8187. 33 indexed citations
16.
Čítek, J., et al.. (2008). Sporadic incidence of factor XI deficiency in Holstein cattle. Journal of the Science of Food and Agriculture. 88(12). 2069–2072. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026